Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
CISH - Cytokine Inducible SH2 Containing Protein
Alias:
CIS
G18
SOCS
CIS-1
BACTS2
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因编码的蛋白质包含一个SH2结构域和一个SOCS盒结构域。因此,该蛋白质属于细胞因子诱导的STAT抑制剂(CIS),也称为细胞因子信号抑制子(SOCS)或STAT诱导的STAT抑制剂(SSI)蛋白质家族。CIS家族成员已知是细胞因子信号的诱导负调节子。这个基因的表达可以在造血细胞中由IL2、IL3、GM-CSF和EPO诱导。已经表明,这个蛋白质的蛋白酶体介导的降解涉及红细胞生成素受体的失活。已经发现这个基因的多个转录变异体,编码不同的异构体。[RefSeq,2008年8月提供]
Related ID:
NCBI:1154
ENSEMBL:ENSG00000114737
HGNC:1984
UNIPROT:Q9NSE2
OMIM:602441
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
1154
3
3
5286 bp
28.66
13
2
10
8
CISH Genetics information (-)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top